Kymera Therapeutics (KYMR) Times Interest Earned (2019 - 2025)
Historic Times Interest Earned for Kymera Therapeutics (KYMR) over the last 7 years, with Q3 2025 value amounting to -$944.09.
- Kymera Therapeutics' Times Interest Earned rose 2146.09% to -$944.09 in Q3 2025 from the same period last year, while for Sep 2025 it was -$985.93, marking a year-over-year decrease of 1918.33%. This contributed to the annual value of -$1050.7 for FY2024, which is 2441.59% down from last year.
- According to the latest figures from Q3 2025, Kymera Therapeutics' Times Interest Earned is -$944.09, which was up 2146.09% from -$782.94 recorded in Q2 2025.
- Kymera Therapeutics' 5-year Times Interest Earned high stood at -$371.38 for Q4 2023, and its period low was -$1402.7 during Q3 2023.
- Moreover, its 5-year median value for Times Interest Earned was -$883.21 (2021), whereas its average is -$884.82.
- Its Times Interest Earned has fluctuated over the past 5 years, first soared by 4327.8% in 2023, then plummeted by 26854.75% in 2024.
- Over the past 5 years, Kymera Therapeutics' Times Interest Earned (Quarter) stood at -$666.55 in 2021, then rose by 1.77% to -$654.75 in 2022, then surged by 43.28% to -$371.38 in 2023, then tumbled by 268.55% to -$1368.7 in 2024, then skyrocketed by 31.02% to -$944.09 in 2025.
- Its Times Interest Earned was -$944.09 in Q3 2025, compared to -$782.94 in Q2 2025 and -$1033.7 in Q1 2025.